CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for STAAR Surgical Co is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

STAAR Surgical Co
1911 Walker Ave
Phone: (626) 303-7902p:626 303-7902 MONROVIA, CA  91016  United States Ticker: STAASTAA
Business Summary
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/27/202412/29/2023YesYes-Yes-

Industries
SIC Code Description
3851 Ophthalmic goods
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Thomas G.Frinzi 68 1/1/2023 6/1/2020
Chief Financial Officer Patrick F.Williams 51 7/6/2020 7/6/2020
Chief Operating Officer WarrenFoust 48 4/24/2023 4/24/2023
10 additional Officers and Directors records available in full report.

Business Names
Business Name
STAA
STAAR Japan Godo Kaisha
STAAR Japan Inc.
6 additional Business Names available in full report.

General Information
Number of Employees: 1,056 (As of 12/29/2023)
Outstanding Shares: 49,275,875 (As of 10/25/2024)
Shareholders: 265
Stock Exchange: NASD
Federal Tax Id: 953797439
Fax Number: (302) 636-5454
Email Address: exeoffices@staar.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024